ECSP044989A - CISTEINE PROTEASE INHIBITORS WITH 2-CIANO-4-AMINO-PYRIMIDINE STRUCTURE AND CATEPSIN K INHIBITOR ACTIVITY FOR THE TREATMENT OF INFLAMMATIONS AND OTHER DISEASES - Google Patents
CISTEINE PROTEASE INHIBITORS WITH 2-CIANO-4-AMINO-PYRIMIDINE STRUCTURE AND CATEPSIN K INHIBITOR ACTIVITY FOR THE TREATMENT OF INFLAMMATIONS AND OTHER DISEASESInfo
- Publication number
- ECSP044989A ECSP044989A EC2004004989A ECSP044989A ECSP044989A EC SP044989 A ECSP044989 A EC SP044989A EC 2004004989 A EC2004004989 A EC 2004004989A EC SP044989 A ECSP044989 A EC SP044989A EC SP044989 A ECSP044989 A EC SP044989A
- Authority
- EC
- Ecuador
- Prior art keywords
- diseases
- treatment
- cisteine
- catepsin
- ciano
- Prior art date
Links
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La invención proporciona compuestos de la fórmula I o una sal o éster de los mismos farmacéuticamente aceptables (I), en donde los símbolos tienen el significado como se define, los cuales son inhibidores de la catepsina K y encuentran uso farmacéutico para el tratamiento de enfermedades y condiciones médicas en las cuales se encuentra involucrada la catepsina K, por ejemplo, diversos padecimientos que incluyen inflamación, artritis reumatoide, osteoartritis, osteoporosis y tumoresThe invention provides compounds of the formula I or a pharmaceutically acceptable salt or ester thereof (I), wherein the symbols have the meaning as defined, which are cathepsin K inhibitors and find pharmaceutical use for the treatment of diseases. and medical conditions in which cathepsin K is involved, for example, various conditions that include inflammation, rheumatoid arthritis, osteoarthritis, osteoporosis and tumors
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0121026.9A GB0121026D0 (en) | 2001-08-30 | 2001-08-30 | Organic compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP044989A true ECSP044989A (en) | 2004-04-28 |
Family
ID=9921227
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EC2004004989A ECSP044989A (en) | 2001-08-30 | 2004-02-26 | CISTEINE PROTEASE INHIBITORS WITH 2-CIANO-4-AMINO-PYRIMIDINE STRUCTURE AND CATEPSIN K INHIBITOR ACTIVITY FOR THE TREATMENT OF INFLAMMATIONS AND OTHER DISEASES |
Country Status (4)
| Country | Link |
|---|---|
| EC (1) | ECSP044989A (en) |
| GB (1) | GB0121026D0 (en) |
| NO (1) | NO20040858L (en) |
| ZA (1) | ZA200400677B (en) |
-
2001
- 2001-08-30 GB GBGB0121026.9A patent/GB0121026D0/en not_active Ceased
-
2004
- 2004-01-28 ZA ZA200400677A patent/ZA200400677B/en unknown
- 2004-02-26 NO NO20040858A patent/NO20040858L/en not_active Application Discontinuation
- 2004-02-26 EC EC2004004989A patent/ECSP044989A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO20040858L (en) | 2004-05-21 |
| GB0121026D0 (en) | 2001-10-24 |
| ZA200400677B (en) | 2004-12-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP044998A (en) | PIRROLO PIRIMIDINAS AS AGENTS FOR THE INHIBITION OF CYSTEINE PROTEASES | |
| BR0212141A (en) | Cysteine protease inhibitors with 2-cyano-4-amino-pyrimidine structure and cathepsin k inhibitory activity for the treatment of inflammation and other diseases | |
| GB0220187D0 (en) | Organic compounds | |
| DK1601677T3 (en) | Spirosubstituted pyrrolopyrimidines | |
| CO5271715A1 (en) | 7-AZA-INDOLIN-2-WAVES SUBSTITUTED IN 4 AND ITS USE AS PROTEIUNA QUINASA INHIBITORS | |
| UY27167A1 (en) | MATRIX METALOPROTEINAS PYRIDINE INHIBITORS | |
| PT1259512E (en) | PTERIDIN COMPOUNDS FOR PSORIASIS TREATMENT | |
| UY27154A1 (en) | MATRIX METALOPROTEINASE INHIBITING PYRIMIDINS | |
| DK1420801T3 (en) | Use of fucans for the treatment of adhesions, arthritis and psoreasis | |
| SV2004001414A (en) | INHIBITORS OF FACTOR XA AND OTHER SERINE PROTEASES INVOLVED IN THE COAGULATION WATERFALL. PC20535 | |
| CU23218A3 (en) | NEW SPIROCICLIC DERIVATIVES AND ITS USE AS PHOSPHODIESTERASE INHIBITORS - 7 | |
| CY1108748T1 (en) | USE OF IL-18 INHIBITORS FOR TREATMENT AND / OR PREVENTION OF REGULAR VASCULAR DISEASES | |
| ES2181614T3 (en) | SULFONYL PHENYL HETEROCICLES REPLACED AS INHIBITORS OF CYCLOOXYGENASA-2 AND 5-LIPOXYGENASE. | |
| BR0316680A (en) | Chk, pdk and akt inhibitor pyrimidines, their production and use as pharmaceutical agents | |
| PA8583401A1 (en) | NEW TRIAZOL COMPOUNDS AS INHIBITORS OF THE TRANSFORMING GROWTH FACTOR (TGF) | |
| GT200500007A (en) | [1,8] NAFTIRIDIN-2-WAVES AND RELATED COMPOUNDS FOR THE TREATMENT OF CHICHOPHRENIA. | |
| GT200100132A (en) | PIRAZOL DERIVATIVES | |
| HN2001000244A (en) | SPIROPIRIMIDIN INHIBITORS - 2, 4, 6 - TRIONA METALOPROTEINASAS. | |
| PA8583101A1 (en) | NEW COMPOUNDS OF ISOTIAZOL AND ISOXAZOL AS INHIBITORS OF THE TRANSFORMING GROWTH FACTOR (TGF) | |
| ATE438618T1 (en) | INHIBITORS OF HUMAN ADAM-10 | |
| EA200401183A1 (en) | APPLICATION OF IL-18 INHIBITORS AS A DIAGNOSTIC MARKER | |
| ECSP055745A (en) | DERIVATIVES OF 1- (4-BENCIL-PIPERAZIN-1-IL) -3-FENIL-PROPENONA | |
| PA8571601A1 (en) | SELECTIVE INHIBITORS OF CICLOOXIGENASA-2 | |
| SE0002739D0 (en) | New use | |
| ECSP044989A (en) | CISTEINE PROTEASE INHIBITORS WITH 2-CIANO-4-AMINO-PYRIMIDINE STRUCTURE AND CATEPSIN K INHIBITOR ACTIVITY FOR THE TREATMENT OF INFLAMMATIONS AND OTHER DISEASES |